<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 7: Pharmacokinetic Parameters for Didanosine in HIV-infected Patients 
			</caption>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<col></col>
<thead>
<tr>
<th rowspan="2" stylecode="Lrule Rrule Toprule">
<br/>Parameter<sup>a</sup>
</th>
<th align="center" colspan="2" stylecode="Lrule Rrule Toprule">Pediatrics</th>
<th align="center" colspan="2" stylecode="Lrule Rrule Toprule">Adults</th>
</tr>
<tr>
<th align="center" stylecode="Lrule Rrule Toprule">20 kg to less <br/>than 25 kg<br/>n=10</th>
<th align="center" stylecode="Lrule Rrule Toprule">25 kg to less <br/>than 60 kg<br/>n=17</th>
<th align="center" stylecode="Lrule Rrule Toprule">At least 60 kg <br/>n=7</th>
<th align="center" stylecode="Lrule Rrule Toprule">At least 60 kg <br/>n=44</th>
</tr>
</thead>
<tfoot>
<tr>
<td colspan="5">a The pharmacokinetic parameters (mean ± standard deviation) of didanosine were determined by a population pharmacokinetic model based on combined clinical studies.<br/>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Lrule Rrule" valign="top">   Apparent clearance (L/h)<br/>   Apparent volume of distribution (L) <br/>   Elimination half-life (h)<br/>   Steady-state AUC (mg•h/L)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">89.5 ± 21.6<br/>98.1 ± 30.2<br/>0.75 ± 0.13<br/>2.38 ± 0.66<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">116.2 ± 38.6<br/>154.7 ± 55<br/>0.92 ± 0.09<br/>2.36 ± 0.7<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">196 ± 55.8<br/>363 ± 137.7<br/>1.26 ± 0.19<br/>2.25 ± 0.89<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">174.5 ± 69.7<br/>308.3 ± 164.3<br/>1.19 ± 0.21<br/>2.65 ± 1.07<br/>
</td>
</tr>
</tbody>
</table>